Filing Details
- Accession Number:
- 0001209191-22-043574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-01 06:00:24
- Reporting Period:
- 2022-07-31
- Accepted Time:
- 2022-08-01 06:00:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821447 | Alejandro Galindo | 1 Casper Street Danbury CT 06810 | Evp Endocrine Business Unit | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2022-07-31 | 5,000 | $2.93 | 781,690 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2022 representing the maximum allowable under the Plan for this period.
Billionaire Hedge Funds
